Deferred Tax Assets, Operating Loss Carryforwards of ENvue Medical, Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: ENvue Medical, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
ENvue Medical, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $9,032,000, a 6.4% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

ENvue Medical, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$9,032,000	+$546,000	+6.4%	31 Dec 2024	10-K	31 Mar 2025	2024	FY
Q4 2023	$8,486,000	-$7,297,514,000		31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q4 2022	$7,306,000,000^*	+$7,299,437,000		31 Dec 2022	10-K	08 Apr 2024	2023	FY
Q4 2021	$6,563,000	+$6,557,288		31 Dec 2021	10-K	17 Apr 2023	2022	FY
Q4 2020	$5,712^*	+$905		31 Dec 2020	10-K	15 Apr 2022	2021	FY
Q4 2019	$4,807^*	-$3,741,193		31 Dec 2019	10-K	15 Apr 2021	2020	FY
Q4 2018	$3,746,000	+$1,024,000	+38%	31 Dec 2018	10-K	20 May 2020	2019	FY
Q4 2017	$2,722,000	-$1,172,000	-30%	31 Dec 2017	10-K	13 May 2019	2018	FY
Q4 2016	$3,894,000	-$856,000	-18%	31 Dec 2016	10-K	29 Mar 2018	2017	FY
Q4 2015	$4,750,000	+$864,000	+22%	31 Dec 2015	10-K/A	26 Jul 2017	2016	FY
Q4 2014	$3,886,000			31 Dec 2014	10-K	30 Mar 2016	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.